Spatial clonal evolution leading to ibrutinib resistance and disease progression in chronic lymphocytic leukemia

• Richárd Kiss,
• Donát Alpár,
• Ambrus Gángó,
• Noémi Nagy,
• Ediz Eyupoglu,
• Dóra Aczél,
• András Matolcsy,
• Judit Csomor,
• Zoltán Mátrai,
• Csaba Bödör

Affiliations

Richárd Kiss

MTA-SE Momentum Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest

Donát Alpár

MTA-SE Momentum Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest

Ambrus Gángó

MTA-SE Momentum Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest

Noémi Nagy

MTA-SE Momentum Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest

Ediz Eyupoglu

MTA-SE Momentum Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest

Dóra Aczél

MTA-SE Momentum Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest

András Matolcsy

MTA-SE Momentum Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest

Judit Csomor

MTA-SE Momentum Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest

Zoltán Mátrai

Department of Haematology and Stem Cell Transplantation, St. István and St László Hospital, Budapest, Hungary

Csaba Bödör

MTA-SE Momentum Molecular Oncohematology Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest